Status:
UNKNOWN
Multicentric Retrospective Review of Extracapsular Lymph Node Involvement After Esophagectomy
Lead Sponsor:
University Hospital, Gasthuisberg
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
It is well known that lymph node metastasis is one of the most important prognostic factors in oesophageal carcinoma. The investigators want to determine the influence of lymph node characteristics, ...
Detailed Description
The classification of carcinoma of the esophagus has undergone a major modification between the UICC sixth (TNM-6) and TNM-7 edition. Regional lymph nodes (N) are now subdivided by the number of invol...
Eligibility Criteria
Inclusion
- Adequate lymph node sampling is of paramount importance. (pT1 - min. 10 LN; \>pT2 min. 20 LN resected). At least the following lymph node stations should be examined: perioesophageal distal 1/3 and perigastric LN, left gastric artery, splenic artery, common hepatic artery, subcarinal lymph nodes. Sugical technique (transthoracic, transhiatal or minimal invasive) is less important if the criterium of adequate lymph node sampling is fulfilled but should be mentioned.
Exclusion
- unforeseen organ metastasis
- subcardia tumors
- histology other than adenocarcinoma or squamous cell carcinoma
- Postoperative (inhospital or 30-day) mortality
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2013
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT01837173
Start Date
March 1 2013
End Date
November 1 2013
Last Update
April 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Leuven, Gasthuisberg
Leuven, Belgium, 3000